Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Australian Family Physician|October 31, 2002
Guidelines for the treatment of postmenopausal osteoporosis for general practitionersSheila O'Neill, Philip Sambrook, Terry Diamond, et al.
Diabetologia|April 26, 2018
A proinflammatory CD4<sup>+</sup> T cell phenotype in gestational diabetes mellitusAngela Sheu, Yixian Chan, Angela Ferguson, et al.
Journal of the American College of Cardiology|September 25, 2012
R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathyStefan A Mann, Maria L Castro, Monique Ohanian, et al.
Diabetes/Metabolism Research and Reviews|March 9, 2023
Factors associated with fragility fractures in type 2 diabetes: An analysis of the randomised controlled Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyAngela Sheu, Rachel L O'Connell, Alicia J Jenkins, et al.
The Lancet. Oncology|December 24, 2018
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trialJames W Denham, David Joseph, David S Lamb, et al.
The Lancet. Oncology|August 19, 2014
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trialJames W Denham, David Joseph, David S Lamb, et al.
BJU International|February 12, 2014
Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancerJames W Denham, Michael Nowitz, David Joseph, et al.
Pageof 3